U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07166120) titled 'Precision Treatment to Promote Smoking Cessation and Survival in Oncology Patients' on Sept. 02.
Brief Summary: This study evaluates the feasibility and preliminary effects of precision tobacco treatment, compared to usual care, on promoting tobacco treatment in oncology patients and providers in the oncology care setting. The precision treatment intervention includes personalized tobacco treatment recommendations using the patient's clinical, genetic, and biomarker information. This intervention may increase patient receipt of tobacco treatment, patient medication use, and patient smoking abstinence at 6 months.
Study Start Date:...